Immumem Therapeutics engages in development of scalable and affordable allogeneic iPSC-derived cell therapies using a novel immunological memory platform against lethal cancer types such as pancreatic, colorectal, ovarian, and cervical cancer.
Company Details
- Employees
- 1
- Founded
- -
- Address
- San Francisco, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://immumemtx.com
- HQ
- San Francisco, CA
Immumem Therapeutics Questions
Immumem Therapeutics's website is https://immumemtx.com
Immumem Therapeutics's LinkedIn profile is https://www.linkedin.com/company/immumemtx
Immumem Therapeutics has
1 employees.
View email and phone details for 1
employees at Immumem Therapeutics.
Immumem Therapeutics's industry is
Biotechnology Research
Immumem Therapeutics's top competitors are
Brand Pro Max,
Ligronbio Inc,
Footballmoney,
Wakepackgo,
Kanda Technologies,
Talk2flow,
Smartpaths,
Kithli: Bridging A Critical Healthcare Gap, Patient Companions Bringing You Home With Care,
Fueldash Inc,
Azodha.
Immumem Therapeutics's categories are Biotechnology Research
Immumem Therapeutics's founding year is 2024
